title: Update on HIV dementia and HIV-associated neurocognitive disorders.
abstract: The introduction of combined antiretroviral therapy (cART) has dramatically reduced the risk of central nervous system opportunistic infection and severe dementia secondary to HIV infection in the last two decades. However, a milder form of HIV-associated neurocognitive disorder (HAND) remains prevalent in the cART era and has a significant impact on patients' quality of life. In this review, we outline updated research findings on investigating and monitoring cognitive impairment in HAND patients. The outcomes of recent research on the pathogenesis of HAND and how it overlaps with neurodegenerative diseases are discussed. Lastly, there is a brief discussion of the results of clinical trials using a brain-penetrating cART regimen.
authors.affiliation: St Vincent's Clinical School, University of New South Wales, Darlinghurst, NSW, 2010, Australia, B.Brew@UNSW.edu.au.
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Brew
authors.forename: Phillip
authors.initials: P
authors.lastname: Chan
mesh_terms: D015526:AIDS Dementia Complex; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015658:HIV Infections / Q000150:complications*; D006801:Humans